Risk factors for lipodystrophy in the CISAI cohort.

Purpose: This study set out to describe the frequency of lipodystrophy, and identify its risk factors, in HIV-positive patients treated with HAART containing at least one protease inhibitor (PI). We analyzed the data collected in the CISAI study.

Methods: The CISAI is a multicenter cohort study that has enrolled 1480 patients.